What was Airsculpt Technologies Inc (AIRS)’s performance in the last session?

While Airsculpt Technologies Inc has underperformed by -0.99%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AIRS rose by 19.90%, with highs and lows ranging from $9.20 to $1.53, whereas the simple moving average jumped by 7.27% in the last 200 days.

On October 17, 2024, BTIG Research started tracking Airsculpt Technologies Inc (NASDAQ: AIRS) recommending Neutral. A report published by Leerink Partners on May 14, 2024, Downgraded its rating to ‘Market Perform’ for AIRS. Piper Sandler also Downgraded AIRS shares as ‘Neutral’, setting a target price of $4 on the company’s shares in a report dated November 11, 2022. Morgan Stanley June 16, 2022d the rating to Equal-Weight on June 16, 2022, and set its price target from $17 to $8.50. SVB Leerink initiated its ‘Outperform’ rating for AIRS, as published in its report on November 23, 2021. Raymond James’s report from November 23, 2021 suggests a price prediction of $18 for AIRS shares, giving the stock a ‘Outperform’ rating. Piper Sandler also rated the stock as ‘Overweight’.

Analysis of Airsculpt Technologies Inc (AIRS)

Further, the quarter-over-quarter decrease in sales is -17.32%, showing a negative trend in the upcoming months.

In order to gain a clear picture of Airsculpt Technologies Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -21.30% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.57, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

An average volume of 548.11K can be a very valuable indicator of volatility for AIRS stock. On a monthly basis, the volatility of the stock is set at 5.05%, whereas on a weekly basis, it is put at 10.21%, with a loss of -2.15% over the past seven days. Furthermore, long-term investors anticipate a median target price of $4.75, showing decline from the present price of $5.00, which can serve as yet another indication of whether AIRS is worth investing in or should be passed over.

How Do You Analyze Airsculpt Technologies Inc Shares?

In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 81.80%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 22.10% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

AIRS shares are owned by institutional investors to the tune of 22.10% at present.

Hot this week

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

Topics

GDS Holdings Limited ADR (GDS) stock analysis: A simple moving average approach

While GDS Holdings Limited ADR has overperformed by 0.11%,...

Tronox Holdings plc (TROX)’s highs and lows: A closer look at its stock price fluctuations

While Tronox Holdings plc has overperformed by 0.18%, investors...

A year in review: Esperion Therapeutics Inc (ESPR)’s performance in the last year

While Esperion Therapeutics Inc has overperformed by 0.92%, investors...

TOI overperforms with a 1.71 increase in share price

While Oncology Institute Inc has overperformed by 1.71%, investors...

Technical analysis of Insmed Inc (INSM) stock chart patterns

While Insmed Inc has underperformed by -0.82%, investors are...

A stock that deserves closer examination: Perpetua Resources Corp (PPTA)

While Perpetua Resources Corp has overperformed by 2.68%, investors...

Perspective Therapeutics Inc (CATX) deserves deeper analysis

While Perspective Therapeutics Inc has underperformed by -2.27%, investors...

Was Foremost Clean Energy Ltd (FMST)’s session last reading good?

While Foremost Clean Energy Ltd has overperformed by 2.80%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.